| Value | ₹5.25 Cr |
|---|
BSE filing, NSE: GODAVARI. Summary written from the filing by ALFA Finder's alert engine.
Godavari Drugs Ltd: key numbers
- Share price
- ₹125.60
- Market cap
- ₹127.2 Cr
- Revenue (annual)
- ₹105.8 Cr
- Net profit (annual)
- ₹4.09 Cr
- P/E (TTM)
- 30.6×Sector 45.9×
- Promoter holding
- 40.23%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Drugs Ltd
All →Godavari Drugs Other Announcement
Godavari Drugs Limited changed its Corporate Identification Number (CIN) following an alteration to its Memorandum of Association's Object Clause. The Ministry of Corporate Affairs registered the change on October 16, 2026.
Godavari Drugs Debt & Borrowing: ₹34 Cr
Godavari Drugs Limited's board approved availing working capital limits of Rs. 34 Crore from ICICI Bank. The facility is within existing shareholder-approved borrowing limits.
- Value
- ₹34.00 Cr
Godavari Drugs Annual General Meeting
Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.
Godavari Drugs Annual General Meeting
Godavari Drugs Limited will close its register of members and share transfer books from September 19 to September 25, 2026, for its 38th Annual General Meeting.
Godavari Drugs Board Meeting Outcome
Godavari Drugs approved altering its Memorandum of Association to add a nutraceuticals business object. A revised notice for the 38th AGM was also approved.
Godavari Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 10.0% YoY
Godavari Drugs Ltd reported revenue from operations of ₹28 Cr (+17.6% YoY) and net profit of ₹1.1 Cr (+10.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +10.0% YoY
Other capital structure change announcements
All →OnMobile Global Capital Structure Change
Ajay Shivnarayan Upadhyaya bought 5.25 lakh OnMobile Global shares, lifting his stake from 4.70% to 5.20%. It is a non-promoter open-market purchase disclosed under SAST Regulation 29(1).
Styrenix Performance Materials Capital Structure Change
Bandhan Mutual Fund lifted its Styrenix stake to 5.0062% via 15,000 open-market shares bought on October 29, 2026. The non-promoter SAST disclosure states no transaction value.
One Point One Solutions Capital Structure Change
One Point One Solutions disclosed its subsidiary issued 1.57 crore bonus shares to the parent. The parent's stake in the subsidiary now stands at 62.75%.
Artificial Electronics Intelligent Material Capital Structure Change
AEIM's board withdrew its proposed ₹166 Crore rights issue citing unfavourable market conditions. The company may reconsider fundraising at a later appropriate time.
- Value
- ₹166.0 Cr
LG Balakrishnan & Bros Capital Structure Change
LG Balakrishnan & Bros will invest Rs 9.79 Crore in its subsidiary SLGB Energy Solutions via rights subscription. The funds support commencement of commercial operations.
- Value
- ₹9.79 Cr
LG Balakrishnan & Bros Capital Structure Change
LG Balakrishnan & Bros will invest Rs 15.01 Crore via rights subscription in its wholly owned subsidiary. The investment supports expansion of the subsidiary's business.
- Value
- ₹15.01 Cr